Hubei Hongyuan Pharmaceutical Technology Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 62.28% vs 1.74% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 1,538.64% vs -71.79% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "703.50",
          "val2": "433.50",
          "chgp": "62.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "155.80",
          "val2": "54.80",
          "chgp": "184.31%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.60",
          "val2": "3.10",
          "chgp": "-16.13%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "1.50",
          "val2": "3.70",
          "chgp": "-59.46%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "144.20",
          "val2": "8.80",
          "chgp": "1,538.64%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "221.40%",
          "val2": "11.10%",
          "chgp": "21.03%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 9.46% vs -13.72% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 128.35% vs -40.94% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,936.90",
          "val2": "1,769.50",
          "chgp": "9.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "323.40",
          "val2": "214.90",
          "chgp": "50.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "15.40",
          "val2": "13.70",
          "chgp": "12.41%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "2.80",
          "val2": "5.40",
          "chgp": "-48.15%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "117.60",
          "val2": "51.50",
          "chgp": "128.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "61.00%",
          "val2": "18.60%",
          "chgp": "4.24%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

703.50

433.50

62.28%

Operating Profit (PBDIT) excl Other Income

155.80

54.80

184.31%

Interest

2.60

3.10

-16.13%

Exceptional Items

1.50

3.70

-59.46%

Consolidate Net Profit

144.20

8.80

1,538.64%

Operating Profit Margin (Excl OI)

221.40%

11.10%

21.03%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is 62.28% vs 1.74% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is 1,538.64% vs -71.79% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

1,936.90

1,769.50

9.46%

Operating Profit (PBDIT) excl Other Income

323.40

214.90

50.49%

Interest

15.40

13.70

12.41%

Exceptional Items

2.80

5.40

-48.15%

Consolidate Net Profit

117.60

51.50

128.35%

Operating Profit Margin (Excl OI)

61.00%

18.60%

4.24%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 9.46% vs -13.72% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 128.35% vs -40.94% in Dec 2024

All Annual Results